Herpes simplex virus (HSV) infections in the neonatal period continue to be troublesome for practitioners. In the 1970s, the drug vidarabine was introduced, but it was extremely toxic to the neonate, and there was little improvement in outcomes. The development of acyclovir in the 1980s led to significant improvements in the survival of infected infants. Mortality of infants with the disseminated disease has decreased from 85 percent to 29 percent, and patients with central nervous system (CNS) disease has decreased from 50 percent to roughly 4 percent in industrialized countries. This activity reviews the evaluation and management of neonatal herpes and stresses the role of the interprofessional team in the care of affected patients.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/22837
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Pediatrics, General Surgery, Hospital Medicine, Infectious Diseases/Medical Microbiology, Neonatal-Perinatal Medicine, Neurodevelopmental Disabilities, Pediatric Infectious Diseases, Pediatric Neurology
Subscribe
Login
0 Comments
Oldest